clofibrate has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrera, G; Briatore, F; Dianzani, MU; Ferretti, C; Laurora, S; Pizzimenti, S | 1 |
| Cajaraville, MP; Herrero, A; Ibabe, A | 1 |
| Canuto, RA; Maggiora, M; Muzio, G; Oraldi, M | 1 |
3 other study(ies) available for clofibrate and 9-deoxy-delta-9-prostaglandin d2
| Article | Year |
|---|---|
Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation.
Topics: Aldehydes; Cell Differentiation; Cell Division; Chromans; Clofibrate; Clofibric Acid; Drug Synergism; Fibric Acids; HL-60 Cells; Humans; Ligands; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; U937 Cells | 2002 |
Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes.
Topics: Animals; Cell Nucleus; Cell Proliferation; Cell Separation; Cell Survival; Clofibrate; Cytoplasm; Estradiol; Hepatocytes; Hydroxyeicosatetraenoic Acids; Hypolipidemic Agents; Immunohistochemistry; In Vitro Techniques; Ligands; PPAR alpha; PPAR gamma; Prostaglandin D2; Zebrafish | 2005 |
Involvement of PPARĪ± and PPARĪ³ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells.
Topics: Apoptosis; bcl-Associated Death Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Clofibrate; Hep G2 Cells; Humans; Ligands; Liver Neoplasms; Osmolar Concentration; PPAR alpha; PPAR gamma; Prostaglandin D2; Protein Phosphatase 2; Proto-Oncogene Proteins c-myc; Signal Transduction; Time Factors | 2010 |